Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Science of the Total Environment|March 22, 2022
Climate change and air pollution: Translating their interplay into present and future mortality risk for Rome and Milan municipalitiesM Michetti, M Gualtieri, A Anav, et al.
Veterinary Microbiology|December 22, 1999
Occurrence and characterization of gastric Helicobacter spp. in naturally infected dogsG Cattoli, R van Vugt, R G Zanoni, et al.
The AAPS Journal|February 17, 2024
Characterization of CYP3A5 Selective Inhibitors for Reaction Phenotyping of Drug CandidatesJie Chen, Lloyd Wei Tat Tang, Samantha Jordan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting ApproachAngela C Doran, Woodrow Burchett, Connor Landers, et al.
Veterinary Journal (London, England : 1997)|November 4, 2015
Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomesE M Pérez-Merino, J M Usón-Casaús, C Zaragoza-Bayle, et al.
The Journal of Small Animal Practice|February 9, 2010
Emesis in dogs: a reviewC Elwood, P Devauchelle, J Elliott, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2024
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri, et al.
Veterinary Journal (London, England : 1997)|November 4, 2015
Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomesE M Pérez-Merino, J M Usón-Casaús, J Duque-Carrasco, et al.
Pageof 6